S&P 500   3,365.50 (-0.43%)
DOW   29,186.49 (-0.72%)
QQQ   234.33 (-0.13%)
AAPL   317.99 (-2.14%)
MSFT   186.75 (+0.76%)
GOOGL   1,518.91 (+0.01%)
CGC   22.56 (+1.94%)
NVDA   292.64 (+0.98%)
BABA   219.14 (-0.22%)
GE   12.72 (-0.93%)
TSLA   850.82 (+6.35%)
AMD   57.65 (+4.23%)
T   38.22 (-0.08%)
F   8.04 (-0.74%)
NFLX   387.88 (+1.97%)
PRI   135.78 (-0.77%)
BAC   34.24 (-1.78%)
GILD   66.91 (-0.96%)
S&P 500   3,365.50 (-0.43%)
DOW   29,186.49 (-0.72%)
QQQ   234.33 (-0.13%)
AAPL   317.99 (-2.14%)
MSFT   186.75 (+0.76%)
GOOGL   1,518.91 (+0.01%)
CGC   22.56 (+1.94%)
NVDA   292.64 (+0.98%)
BABA   219.14 (-0.22%)
GE   12.72 (-0.93%)
TSLA   850.82 (+6.35%)
AMD   57.65 (+4.23%)
T   38.22 (-0.08%)
F   8.04 (-0.74%)
NFLX   387.88 (+1.97%)
PRI   135.78 (-0.77%)
BAC   34.24 (-1.78%)
GILD   66.91 (-0.96%)
S&P 500   3,365.50 (-0.43%)
DOW   29,186.49 (-0.72%)
QQQ   234.33 (-0.13%)
AAPL   317.99 (-2.14%)
MSFT   186.75 (+0.76%)
GOOGL   1,518.91 (+0.01%)
CGC   22.56 (+1.94%)
NVDA   292.64 (+0.98%)
BABA   219.14 (-0.22%)
GE   12.72 (-0.93%)
TSLA   850.82 (+6.35%)
AMD   57.65 (+4.23%)
T   38.22 (-0.08%)
F   8.04 (-0.74%)
NFLX   387.88 (+1.97%)
PRI   135.78 (-0.77%)
BAC   34.24 (-1.78%)
GILD   66.91 (-0.96%)
S&P 500   3,365.50 (-0.43%)
DOW   29,186.49 (-0.72%)
QQQ   234.33 (-0.13%)
AAPL   317.99 (-2.14%)
MSFT   186.75 (+0.76%)
GOOGL   1,518.91 (+0.01%)
CGC   22.56 (+1.94%)
NVDA   292.64 (+0.98%)
BABA   219.14 (-0.22%)
GE   12.72 (-0.93%)
TSLA   850.82 (+6.35%)
AMD   57.65 (+4.23%)
T   38.22 (-0.08%)
F   8.04 (-0.74%)
NFLX   387.88 (+1.97%)
PRI   135.78 (-0.77%)
BAC   34.24 (-1.78%)
GILD   66.91 (-0.96%)
Log in

ASX:SRX - Sirtex Medical Stock Price, Forecast & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume959,639 shs
Market CapitalizationN/A
P/E Ratio45.96
Dividend Yield0.89%
BetaN/A
Sirtex Medical Limited, a life-sciences company, develops and delivers oncology treatments using novel small particle technology in the Asia-Pacific, Europe, the Middle East, Africa, and North and South America. The company's principal product is the SIR-Spheres Y-90 resin microspheres, a targeted radioactive treatment for primary and secondary metastatic liver cancer. Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-2-99648400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$218.74 million
Book ValueA$2.85 per share

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive SRX News and Ratings via Email

Sign-up to receive the latest news and ratings for SRX and its competitors with MarketBeat's FREE daily newsletter.


Sirtex Medical (ASX:SRX) Frequently Asked Questions

What is Sirtex Medical's stock symbol?

Sirtex Medical trades on the ASX under the ticker symbol "SRX."

How were Sirtex Medical's earnings last quarter?

Sirtex Medical Limited (ASX:SRX) issued its quarterly earnings data on Wednesday, August, 29th. The medical device company reported $0.74 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.97 by $0.23. View Sirtex Medical's Earnings History.

Has Sirtex Medical been receiving favorable news coverage?

Media headlines about SRX stock have trended neutral recently, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sirtex Medical earned a coverage optimism score of 0.3 on InfoTrie's scale. They also assigned media coverage about the medical device company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the company's share price in the near term. View News Stories for Sirtex Medical.

Who are some of Sirtex Medical's key competitors?

What other stocks do shareholders of Sirtex Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sirtex Medical investors own include Woodside Petroleum (WPL), REA Group (REA), Bristol-Myers Squibb (BMY), WOODSIDE PET LT/ADR (WOPEY), Mantra Group (MTR), IMF Bentham (IMF), Galaxy Resources (GXY), Crown Resorts (CWN), Caltex Australia (CTX) and Corporate Travel Management (CTD).

Who are Sirtex Medical's key executives?

Sirtex Medical's management team includes the folowing people:
  • Mr. Andrew McLean, CEO, MD Exec. Director
  • Mr. Darren Smith M.B.A., B.Bus., FCPA, CFO & Company Sec. (Age 53)
  • Mr. Anthony Dixon, Exec. VP of Sales & Marketing - EMEA
  • Mr. G. Spindler, Global Head of Operations
  • Dr. Thomas Duthy, Global Head of Investor Relations & Corp. Devel.

What is Sirtex Medical's official website?

The official website for Sirtex Medical is http://www.sirtex.com/.

How can I contact Sirtex Medical?

Sirtex Medical's mailing address is L 33 101 Miller St, NORTH SYDNEY, NSW 2060, Australia. The medical device company can be reached via phone at +61-2-99648400.


MarketBeat Community Rating for Sirtex Medical (ASX SRX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  94 (Vote Outperform)
Underperform Votes:  123 (Vote Underperform)
Total Votes:  217
MarketBeat's community ratings are surveys of what our community members think about Sirtex Medical and other stocks. Vote "Outperform" if you believe SRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: What causes a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel